Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells
about
Metaboloepigenetic Regulation of Pluripotent Stem CellsMechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer CellsResidual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cellsIntegration and Fixation Preferences of Human and Mouse Endogenous Retroviruses Uncovered with Functional Data AnalysisValproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.Next-generation mammalian genetics toward organism-level systems biologyFrom transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.Development to term of cloned cattle derived from donor cells treated with valproic acid.Glucocorticoids regulate natural killer cell function epigenetically.H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells.The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.Chromatin landscapes of retroviral and transposon integration profilesAcetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation.Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response.Histone modifications and lamin A regulate chromatin protein dynamics in early embryonic stem cell differentiation.Non-polyadenylated transcription in embryonic stem cells reveals novel non-coding RNA related to pluripotency and differentiationThe histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencingElevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment.The role of hypoxia in pulmonary vascular diseases: a perspective.Chromatin structure, pluripotency and differentiation.Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells.Epigenetic regulation of early neural fate commitment.Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.HDAC inhibitors cause site-specific chromatin remodeling at PU.1-bound enhancers in K562 cells.Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.Production of knock-in mice in a single generation from embryonic stem cells.Sexually Dimorphic Epigenetic Regulation of Brain-Derived Neurotrophic Factor in Fetal Brain in the Valproic Acid Model of Autism Spectrum Disorder.Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.Differential Response of Human Hepatocyte Chromatin to HDAC Inhibitors as a Function of Microenvironmental Glucose Level.Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
P2860
Q26770112-2A378EF1-2287-4768-B5B9-9E3F656C7AD5Q27015931-C761396C-25DE-49D4-86AE-36D61BD72305Q28484378-99B234DC-91A7-4163-B8A8-5F12213D79EDQ30000090-1E31C01C-34CB-4BB2-B24C-2A1B84FDD5FEQ30525523-071E9C77-C92D-4897-9DDF-E27DB7E178C8Q33765741-0B96DEC2-4E6D-4D4B-A578-BD311593C113Q33794480-FD15E359-4C56-4248-9B5F-6B65DBC3139DQ33800837-B90C5B2D-5599-4B86-9A90-84355F58ECD0Q34025712-7A4A7007-086A-4E43-8A2D-21EAD6DD258CQ34393141-32F98FC2-8BE2-47A8-BA6B-BA38F186E5EDQ34771550-1EBEB725-AFFB-43C6-A82B-C954448FBA73Q35003028-339E4478-CBC0-4F1F-8391-A9239F9F03DAQ35144895-B42D819A-EEB6-467D-9D4F-73DE2FFC4C20Q35866275-C7B8963B-1EC1-4F66-A42D-2C8215AABC90Q36067075-42FD0173-49EF-431C-8D6E-6479C919F8C2Q36588126-0C11D838-C605-42F1-94E6-CFC8CEB1AA2EQ36963340-AE9969D3-A4B8-46BF-AB3C-6865A51F557DQ37160553-35C6C862-5E45-4B92-A57D-307795ED75E2Q37228601-38E94B2E-C73D-4ADB-B0CE-8B614AA0CEE7Q37648102-C0A7682C-8AAF-4464-BA43-1A3789DF2076Q38078782-A3146EBB-C6A5-4FFE-9F14-D5445E5468F8Q38100104-0FFCF2EB-C700-4F18-8247-DAA7CD26D0E1Q38698679-7C6DFD49-A12A-49EC-98D9-295ED97B3FAEQ38708405-8B107952-2FB3-491B-9F3E-3CA4287806D9Q38968676-1600643B-C759-4758-A05C-4AF081C1B1E3Q38983619-A5FC133F-C8E0-4EE9-80B1-561C646A4A18Q40252055-CE3344E0-EAA7-44D4-A4D7-791E6264EA49Q42575886-2F639FB7-12DB-4DF9-A9E0-D748DDE3F2BAQ42717337-8065F7E9-8FBF-4595-B4F3-D48D6C5EF01EQ47299621-1BA7BB20-A92D-4D90-92A0-B98CA135C49DQ47597906-DA8885DE-A843-4C65-821B-FE97D267BFCCQ51487802-75E4E67E-1C21-4CFA-A267-BEAC6361FD83Q52884352-5B9529CC-A469-4320-BD7D-F07E767C4A88Q57795852-32D5D920-CA14-430E-91A3-7C363F0ED493
P2860
Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 lysine 9 (H3K9) acetylation patterns in embryonic stem cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pluripotency-related, valproic ...... tterns in embryonic stem cells
@en
type
label
Pluripotency-related, valproic ...... tterns in embryonic stem cells
@en
prefLabel
Pluripotency-related, valproic ...... tterns in embryonic stem cells
@en
P2093
P2860
P356
P1476
Pluripotency-related, valproic ...... tterns in embryonic stem cells
@en
P2093
Badi Sri Sailaja
Eran Meshorer
Hadas Hezroni
P2860
P304
35977-35988
P356
10.1074/JBC.M111.266254
P407
P577
2011-08-17T00:00:00Z